Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Contraception Clinical Trials

A listing of Contraception medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (45) clinical trials

Integrating Family Planning With Immunization to Improve Maternal and Child Health

Study hypothesis: Contraceptive Prevalence Rate will increase up to 20% from the baseline to end line survey in the intervention area .Contraceptive Prevalence Rate will increase by 5% between baseline and end line survey in the control area. Ethics approval: The study has been approved by Population Services International Research ...

Phase N/A

European Active Surveillance Study of LCS12

Intrauterine contraceptive methods, such as Mirena and copper IUDs, have a high contraceptive efficacy. LCS12 is a new intrauterine system which, like Mirena, contains levonorgestrel (LNG), but the T-body dimensions and insertion tube diameter of LCS12 are smaller. Because there is a lack of comparative data between LCS12 and other ...

Phase N/A

Patients are needed to participate in a clinical research study for the treatment of Contraception

The study is designed as non interventional to observe the continuation rate and the patient satisfaction in women who have a LNG-IUS (Levonorgestrel releasing Intrauterine system) inserted for contraception over the period of 12 months under real life condition in India.The study will begin after the study approval by ethics ...

Phase N/A

Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion

The optimal interval between pregnancies is debated, but a duration greater than 11-18 months has been suggested as reducing complications in the subsequent pregnancy. Improved birth spacing can be a key benefit use of long-acting reversible contraception, but delay to initiation can still be problematic.So women who have recently given ...

Phase N/A

Effect of Dolutegravir on Etonogestrel Levels in HIV-infected Women in Botswana

Efavirenz-based antiretroviral therapy is effective in treating HIV and had become standard in the World Health Organization (WHO) guidelines. However, despite its effectiveness in lowering viral load, there is also solid evidence that it decreases the effectiveness of etonogestrel-releasing implants. This presents a difficult clinical scenario in countries where the ...

Phase N/A

Modifiers of Tenofovir in the Female Genital Tract

Two-armed, single visit, pharmacokinetic study to compare tenofovir diphosphate concentrations in cervical tissues of women on Depo-Provera contraception vs non-hormonal contraception.

Phase N/A

Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

The study is aimed at assessing the clinical follow-up and the outcomes of pregnancies exposed to ella, whether due to failure of the emergency contraception or inadvertent exposure during pregnancy.

Phase N/A

Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy

Qlaira is a combined oral contraceptive (COC) containing dienogest/estradiol valerate being the first oral contraceptive delivering estradiol. It has been recently approved in Mexico. To evaluate the clinical profile of this drug combination under routine medical condition, a post-authorization safety study required by Mexican Health Authorities will be conducted in ...

Phase N/A

Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17 -estradiol (1.5mg)

NOMAC-E2 is a novel monophasic oral contraceptive containing a fixed dose of nomegestrol acetate (2.5mg) and 17-estradiol (1.5mg) which is taken for 24 days followed by 4 days of placebo. The most relevant adverse clinical outcome that has been linked to the use of COCs is venous thromboembolism (VTE). Data ...

Phase N/A

A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test

This study has previously been posted by Conceptus, Inc. After acquiring Conceptus, Inc., Bayer is now the sponsor of the trial.

Phase N/A